InsidersTradesSigma
方盛制药 Stock: price and directors' dealings · China · SSE / SZSE (CSRC)
Follow the 方盛制药 stock price and the full management transaction log of the company, a listed issuer based in China. Shares are quoted on CN CN, under the oversight of SSE / SZSE (CSRC). Operating in the Health Care sector, 方盛制药 has recorded 10 reports. Market capitalisation: €4.9bn. The latest transaction was disclosed on 13 May 2025 (Purchase). Among the most active insiders: 何仕. Every trade is accessible without an account.
10
Insider Decl.
0
Thresholds
·
10 ops.
Buy Volume
·
0 ops.
Sell Volume
22Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 2,205 of 25,564 companies
75.1
score / 100
Value70
Quality80
FCF yld6.9%
Earn yld7.5%
EV/EBITDA10.1x
ROE17%
Gross mgn72%
Net mgn18%
Debt/EBITDA1.0x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 13 May 2025
Declarations10 total
10 of 10 declarations